about
HPLC determination of irbesartan in human plasma: its application to pharmacokinetic studies.Vitamin K supplement along with vitamin D and calcium reduced serum concentration of undercarboxylated osteocalcin while increasing bone mineral density in Korean postmenopausal women over sixty-years-oldContribution of N-glucuronidation to efavirenz elimination in vivo in the basal and rifampin-induced metabolism of efavirenz.Carcinoembryonic antigen level can be overestimated in metabolic syndrome.Women with fibromyalgia have lower levels of calcium, magnesium, iron and manganese in hair mineral analysis.Serum Gamma-glutamyl Transferase Concentration Within the Reference Range is Related to the Coronary Heart Disease Risk Prediction in Korean Men: Analysis of the Korea National Health and Nutrition Examination Survey (V-1, 2010 and V-2, 2011).Efficacy and Safety of "URSA Complex" in Subjects with Physical Fatigue: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial.The Effect of Age on the Pharmacokinetics of Udenafil in Healthy Subjects.The effect of Lycii Radicis Cortex extract on bone formation in vitro and in vivo.Serum total bilirubin concentration is inversely correlated with Framingham risk score in Koreans.Selective inhibition of cytochrome P450 2D6 by Sarpogrelate and its active metabolite, M-1, in human liver microsomes.Hair calcium concentration is associated with calcium intake and bone mineral density.High-sensitive LC-MS/MS method for the simultaneous determination of mirodenafil and its major metabolite, SK-3541, in human plasma: application to microdose clinical trials of mirodenafil.The effect of SLCO1B1*15 on the disposition of pravastatin and pitavastatin is substrate dependent: the contribution of transporting activity changes by SLCO1B1*15.Low Levels of Sex Hormone-Binding Globulin Constitute an Independent Risk Factor for Arterial Stiffness in Korean Women.The relationship of alanine aminotransferase to metabolic syndrome in a Korean population.Acid Inhibitory Effect of a Combination of Omeprazole and Sodium Bicarbonate (CDFR0209) Compared With Delayed-Release Omeprazole 40 mg Alone in Healthy Adult Male Subjects.Pharmacokinetic and Pharmacodynamic Comparison of Two Recombinant Human Erythropoietin Formulations, PDA10 and Eprex, in Healthy Korean Male Volunteers: A Randomized, Double-Blinded, Single-Dose, Two-Period Crossover Study.Reliability and Validity of the Korean Version of the Multidimensional Fatigue Inventory (MFI-20): A Multicenter, Cross-Sectional StudyEffect of the potent CYP2D6 inhibitor sarpogrelate on the pharmacokinetics and pharmacodynamics of metoprolol in healthy male Korean volunteers.Duplex pyrosequencing assay of the 388A>G and 521T>C SLCO1B1 polymorphisms in three Asian populationsIdentification of P2Y12 single-nucleotide polymorphisms and their influences on the variation in ADP-induced platelet aggregationThe effect of CYP2C19 genotype on the time course of platelet aggregation inhibition after clopidogrel administrationSimultaneous determination of metoprolol and its metabolites, α-hydroxymetoprolol and O-desmethylmetoprolol, in human plasma by liquid chromatography with tandem mass spectrometry: Application to the pharmacokinetics of metoprolol associated with CY
P50
Q33416989-4F0C3EBC-1031-447C-8E12-E8BD74A9185AQ34210090-F019FD96-F1C8-4C84-B213-AE89D3020777Q34737523-B2695988-E559-4A5A-AD52-31001E9977FCQ35009846-290B20D0-5EC9-41A6-BDAB-60C8CA08E88EQ35333527-CFD0DF30-3B5D-4813-8E24-B937F027E984Q36477184-B402E645-9561-4E29-A8DA-5B49C6D0E79AQ36705426-205C282B-3763-4164-A02D-F8197E8023AEQ38416026-CDDE88C2-A7E6-49A4-867E-9A6150699968Q38937146-60FA3B1D-26CE-4D5A-900F-1B8B3C029F7DQ39616387-76E79661-D97C-455C-A1E6-EAF293BCA8F0Q42708698-CB2E03BF-3D6B-447F-9153-C38B1050B825Q43421709-EAF2B7AC-A161-44D0-880F-C22D676B15AAQ46425275-C998FA80-CAF0-4550-8BC9-971E7609F779Q46647756-80E7D53F-5A63-4B49-9B60-FF5A27B2A2DFQ47095983-398659D4-1AAF-4B5F-9E9B-A6F387A63497Q49391011-ED4D56F7-47A5-48EC-97D4-A36ED893ACAFQ50939778-B8B79C4A-DF1A-4541-BC02-4011F9244131Q51720300-B5213153-FBDD-4D97-ADEB-0D28A7AFC1E9Q53225735-1E9CC4A6-9DBE-412A-9970-72DB794D87B3Q53257546-D3BAC686-8928-4F95-9C79-EA55DABCE9D6Q81586174-20C423FC-7F88-4064-B829-9CF218F57344Q83153891-1D183305-6DCA-418F-B3F8-25DDB6196FD3Q86698881-52527A7F-F7FE-40DC-A5A4-C1AFA4DB41F0Q87477106-3D04F9FA-E8C3-4FED-9EF1-3C7020FB2B0C
P50
description
researcher ORCID ID = 0000-0003-2996-1000
@en
wetenschapper
@nl
name
Doo-Yeoun Cho
@ast
Doo-Yeoun Cho
@en
Doo-Yeoun Cho
@es
Doo-Yeoun Cho
@nl
type
label
Doo-Yeoun Cho
@ast
Doo-Yeoun Cho
@en
Doo-Yeoun Cho
@es
Doo-Yeoun Cho
@nl
prefLabel
Doo-Yeoun Cho
@ast
Doo-Yeoun Cho
@en
Doo-Yeoun Cho
@es
Doo-Yeoun Cho
@nl
P1153
23090136600
P31
P496
0000-0003-2996-1000